As part of the PNRR MOST project – the National Center for Sustainable Mobility, PHSE is collaborating with the Department of Management, Economics, and Industrial Engineering and the Department of Energy at Politecnico di Milano to drive innovation in sustainable logistics.

The project focuses on PHSE’s Lodi Hub as a business case to develop advanced solutions for resilient and flexible logistics systems. These systems are designed to respond swiftly to market demands while minimizing the environmental impact of transportation.

MOST, the National Center for Sustainable Mobility, is a collaborative effort involving 24 universities, the National Research Council (CNR), and 24 major companies, all working together to create mobility solutions that are modern, sustainable, and inclusive across Italy. Through Spoke 10, dedicated to sustainable logistics, PHSE is addressing critical challenges such as energy efficiency in transportation and the cooling impact in transit warehouses, contributing its expertise in pharma logistics.

This partnership represents an important milestone in developing logistics solutions that prioritize sustainability and innovation.

PHSE is proud to announce that we have recently received the Qualifyze Gold Pharma Supplier Award. This prestigious recognition highlights our unwavering commitment to quality, compliance, and excellence in all our operations.

The Gold Rating from Qualifyze affirms that PHSE meets high quality standards across the entire healthcare supply chain.

This award reflects the dedication of our team to ensure the safe and reliable transport of pharmaceuticals, medical isotopes, and other critical healthcare supplies globally, while maintaining strict compliance with all regulatory requirements.

PHSE continues to invest in advancing its capabilities to ensure that our services meet the evolving needs of our clients and contribute to improving patient care worldwide.

At PHSE, we believe that investing in the education and training of young scientists is essential to advancing cancer research and bringing hope to patients and their families. This belief has inspired us to actively support the work of Fondazione AIRC per la ricerca sul cancro ETS, contributing to the funding of a scholarship for a young researcher specializing in pediatric cancer research.

This commitment is more than an investment; it is a promise to support cutting-edge research and provide hope for the future.

We are proud to announce our participation in the 56th Annual Conference of the Society of Nuclear Medicine India (SNMICON 2024), the premier event for nuclear medicine professionals in India.

SNMICON 2024 serves as an important platform to explore the latest advancements in nuclear medicine, exchange innovative ideas and research, and showcase cutting-edge technologies that are shaping the future of the field. It emphasizes collaboration and innovation as key drivers in advancing nuclear medicine and improving patient care.

PHSE is proud to contribute its expertise as a global leader in radiopharma logistics. With advanced solutions for the transportation of medical isotopes used in diagnostics and therapy, PHSE continues to support the needs of healthcare facilities and production plants worldwide.

By providing temperature-controlled logistics, real-time monitoring of shipments, and secure and efficient delivery systems, PHSE remains committed to supporting the nuclear medicine community and fostering advancements that benefit patients globally.

We are proud to announce the expansion of our fleet with new dedicated radiopharma vehicles, further enhancing our licensed network for the transport of medical isotopes used in diagnostics and therapy. These vehicles are engineered to meet the highest standards for the safe and efficient delivery of radiopharmaceuticals by both road and air, offering comprehensive global support to healthcare facilities and production plants.

The newly added vehicles are equipped with state-of-the-art temperature-controlled systems, ADR-compliant technology, and GPS geolocation to ensure precise tracking. Fully compliant with Class 7 regulations across all operational territories, these vehicles reflect PHSE’s unwavering commitment to safety, reliability, and efficiency in the transport of radiopharmaceuticals.

This initiative underscores PHSE’s leadership in radiopharmaceutical logistics, delivering innovative and reliable solutions that prioritize patient care and operational excellence.

Milan, 12 november 2024 – In the report published today on Il Sole 24 Ore, we are among the Italy’s Growth Champions 2025. The award is dedicated to the 500 Italian companies that have experienced the highest revenue growth in the three-year period from 2020 to 2023.

It is a significant public recognition that confirms the high potential of our company, capable of competing increasingly on the international stage.

With an average annual growth of 40% PHSE ranks 293.

Check out the complete list of 500 companies, compiled by il Sole 24 Ore and Statista.

The rankings are available online at the following link:

Ranking Leader della Crescita 2025

Here, the link to the online dossier:

Dossier Leader della Crescita 2025

We are delighted to share our participation at The ONE Forum, organized by the National Marrow Donor Program (NMDP) in Minneapolis. This unique and impactful event brought together over 2,000 professionals from the cell therapy ecosystem to collaborate and shape the future of this life-saving field.

Representing the PHSE Group, our teams from PHSE and Bio Transportes – a PHSE company proudly contributed to this visionary event. Together, we share NMDP’s mission to expand access to life-saving cell therapies for patients battling cancer and blood diseases.

At PHSE, we specialize in providing the highest standard of logistics for time-critical and temperature-sensitive shipments, ensuring patient safety and reliability. Our solutions include:

• Time-Critical and Temperature-Sensitive Logistics: From donor to patient, we handle every step, including temperature-controlled air freight, onboard couriers, last-mile distribution, and white-glove logistics services.
• Global Reliability and Security: We ensure shipments are 100% secure and reliable anywhere in the world.
• Route Risk Assessments: Our meticulous planning ensures zero-defect shipments every time.
• Transparency and Traceability: We provide global temperature and location monitoring for every shipment.
• Certified Packaging Solutions: Our certified thermal parcels and cryogenic dewars guarantee the integrity of cell therapy materials.
• 24/7 Support: Always available, always responsive.

We are honored to have been among the sponsors of this influential event, contributing to a shared vision of improving patient outcomes through innovative logistics solutions. By supporting initiatives like The ONE Forum, we reaffirm our commitment to advancing access to transformative therapies and improving lives worldwide.

Invited by the Fondazione Banca dei Tessuti del Veneto ETS, one of the most important tissue banks in Italy and Europe, we attended the first A.I.BA.T. National Congress (Italian Association of Tissue Banks).

During the event, Gianluca Meneguzzi shared PHSE’s expertise in transporting tissues such as bone, cardiac, vascular, and amniotic membrane, from donor to patient. For years, we have worked closely with ETS to ensure the daily temperature-controlled transport of tissues from the bank to operating theatres.

We are truly proud to be a partner of a center of excellence that in 2023 alone enabled over 6,000 surgeries, improving and saving countless lives.

A special thanks to Diletta Trojan and the A.I.BA.T. scientific committee for kindly inviting us to take part in this important event.